Crohn's & Colitis Foundation Launches New IBD Clinical Trials Community

Applied Clinical Trials

The Crohn's & Colitis Foundation announced the launch of a dedicated Clinical Trials Community for inflammatory bowel diseases (IBD). The community is designed to educate patients, caregivers, and healthcare providers about the clinical trial process, its value, and how to address barriers that exist in enrollment. 

The Crohn's & Colitis Foundation's Clinical Trial Community is made possible by support from AbbVie, Celgene Corporation, Genentech, Inc., and Takeda Pharmaceuticals U.S.A., Inc.

Read the full release here.